Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 17, 2020
Clear
SKU: GMS-2003 Category:

The market size of metabolomics is projected to reach USD 3.92 billion by 2025, increasing at a CAGR of 13.3% during the 2020-2025 forecast. The growth of the metabolomics market is driven by factors such as increased demand for personalized medicine, increased pharmaceutical and biotech R&D spending, and increased need for toxicology testing.

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 1

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 2

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 3

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 4

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 5

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 6

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 7

Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) - 2020 to 2025 8

1 Global Metabolomics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Metabolomics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Metabolomics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Metabolomics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Metabolomics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Metabolomics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Metabolomics Market – By Product & Service (Market Size – & million/billion)
8.1 Metabolomic Instruments
8.2 Metabolomic Bioinformatics Tools and Services

9 Global Metabolomics Market – By Indication
9.1 Cancer
9.2 Cardiovascular Disorders
9.3 Neurological disorders
9.4 Inborn Errors of Metabolism
9.5 Other

10 Global Metabolomics Market – By Application
10.1 Biomarker Discovery
10.2 Drug Discovery/Drug Assessment
10.3 Nutrigenomics
10.4 Toxicology Testing
10.5 Personalized Medicine
10.6 Functional Genomics
10.7 Other

11 Global Metabolomics Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Metabolomics Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Metabolomics Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Danaher Corporation
13.3 Waters Corporation
13.4 Agilent Technologies, Inc.
13.5 Thermo Fisher Scientific Inc.
13.6 Human Metabolome Technologies, Inc.
13.7 Bruker Corporation
13.8 Bio-Rad Laboratories, Inc.
13.9 Biocrates Life Sciences AG
13.10 Shimadzu Corporation
13.11 Leco Corporation
13.12 Company 11 & more

14 Global Metabolomics Market – Appendix
14.1 Sources
14.2 Abbreviations